The Unmet Information and Support Needs of Women with a Family History of Breast Cancer: A Descriptive Survey.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 26142384)

Published in J Genet Couns on February 01, 2003

Authors

Belinda Thewes1, Bettina Meiser, Monica Tucker, Kathy Tucker

Author Affiliations

1: Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Sydney, Australia, b.thewes@unsw.edu.au.

Articles by these authors

Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab (2005) 4.07

Increasing breast reconstruction rates by offering more women a choice. ANZ J Surg (2014) 2.73

The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26

Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet (2006) 2.23

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res (2006) 2.05

Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol (2012) 1.88

Skin cancer-related prevention and screening behaviors: a review of the literature. J Behav Med (2009) 1.85

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncol (2005) 1.77

The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med (2007) 1.74

The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol (2009) 1.70

The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat (2009) 1.52

Usefulness of the Threatening Medical Situations Inventory in individuals considering genetic testing for cancer risk. Patient Educ Couns (2007) 1.44

Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer (2005) 1.42

The utility of genetics in inherited cancer. Med J Aust (2013) 1.39

Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One (2010) 1.36

Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust (2003) 1.32

Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res (2010) 1.32

Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis (2010) 1.27

Public interest in predictive genetic testing, including direct-to-consumer testing, for susceptibility to major depression: preliminary findings. Eur J Hum Genet (2010) 1.26

It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer--an Australian fertility decision aid collaborative group study. J Clin Oncol (2011) 1.20

Attitudes toward organ donation and donor behavior: a review of the international literature. Prog Transplant (2010) 1.20

The role of BRCA mutation testing in determining breast cancer therapy. Nat Rev Clin Oncol (2010) 1.18

The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psychooncology (2003) 1.14

A pilot study reporting outcomes for melanoma patients of a minimal access ilio-inguinal dissection technique based on two incisions. Ann Surg Oncol (2010) 1.13

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. J Med Genet (2012) 1.13

Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genet Med (2006) 1.10

Predictors of breast cancer screening behavior in women with a strong family history of the disease. Breast Cancer Res Treat (2010) 1.10

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genet Med (2009) 1.10

Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes Cancer (2008) 1.05

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res (2008) 1.05

Issues concerning feedback about genetic testing and risk of depression. Br J Psychiatry (2009) 1.04

Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. Int J Cancer (2005) 1.02

Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer (2008) 1.01

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One (2010) 1.01

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat (2007) 0.97

Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat (2002) 0.97

Women's experience of telehealth cancer genetic counseling. J Genet Couns (2010) 0.97

Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study. Psychooncology (2007) 0.97

Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer. Int J Gynecol Cancer (2010) 0.96

"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer. Genet Test Mol Biomarkers (2011) 0.95

Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg (2008) 0.94

Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene (2003) 0.94

Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibility. J Genet Couns (2006) 0.93

Evaluation of a decision aid for prenatal testing of fetal abnormalities: a cluster randomised trial [ISRCTN22532458]. BMC Public Health (2006) 0.93

A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Psychooncology (2008) 0.93

Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? Genet Med (2011) 0.92

Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. J Genet Couns (2007) 0.91

Predictive and diagnostic genetic testing in psychiatry. Clin Lab Med (2010) 0.91

Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol (2013) 0.91

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst (2015) 0.90

Understanding community beliefs of Chinese-Australians about cancer: initial insights using an ethnographic approach. Psychooncology (2005) 0.90

Psychological morbidity in women at increased risk of developing breast cancer: a controlled study. Psychooncology (2005) 0.89

The virtual consultation: practitioners' experiences of genetic counseling by videoconferencing in Australia. Telemed J E Health (2010) 0.89

100 years Lynch syndrome: what have we learned about psychosocial issues? Fam Cancer (2013) 0.89

Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery. Fam Cancer (2012) 0.88

Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genet Test (2004) 0.88

The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer. Genet Med (2008) 0.87

Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome). Fam Cancer (2011) 0.87

Reducing Psychological Distress in a Genetic Counseling Consultation for Breast Cancer. J Genet Couns (2003) 0.87

Psychosocial impact of familial adenomatous polyposis on young adults: a qualitative study. J Genet Couns (2009) 0.86

Predictive and diagnostic genetic testing in psychiatry. Psychiatr Clin North Am (2010) 0.85

Development and pilot testing of a fertility decision aid for young women diagnosed with early breast cancer. Breast J (2010) 0.85

Evaluation of the needs and concerns of partners of women at high risk of developing breast/ovarian cancer. Psychooncology (2006) 0.84

High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective. Psychooncology (2008) 0.84

Exploring general practitioners' experience of informing women about prenatal screening tests for foetal abnormalities: a qualitative focus group study. BMC Health Serv Res (2008) 0.84

To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk. Genet Test Mol Biomarkers (2012) 0.83

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer (2012) 0.83

Impact of familial adenomatous polyposis on young adults: attitudes toward genetic testing, support, and information needs. Genet Med (2006) 0.83

Community attitudes to genetic susceptibility-based mental health interventions for healthy people in a large national sample. J Affect Disord (2011) 0.83

The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. J Sex Med (2013) 0.82

Community attitudes towards mental health interventions for healthy people on the basis of genetic susceptibility. Aust N Z J Psychiatry (2009) 0.82

An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations. Fam Cancer (2011) 0.82

Development and pilot testing of an online screening decision aid for men with a family history of prostate cancer. Patient Educ Couns (2010) 0.81

Differences in individual approaches: communication in the familial breast cancer consultation and the effect on patient outcomes. J Genet Couns (2005) 0.81

When the risks are high: psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qual Health Res (2012) 0.81

Genetic services for men: the preferences of men with a family history of prostate cancer. Genet Med (2006) 0.81

Psycho-educational interventions for melanoma survivors: a systematic review. Psychooncology (2012) 0.81

Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer. Genet Med (2012) 0.81

Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer. Fam Cancer (2015) 0.80

A balancing act--telehealth cancer genetics and practitioners' experiences of a triadic consultation. J Genet Couns (2009) 0.80

Knowledge, attitudes and beliefs of Arabic-Australians concerning cancer. Psychooncology (2010) 0.80

Younger age-at-diagnosis for familial malignant testicular germ cell tumor. Fam Cancer (2009) 0.80

Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2). Genet Test (2008) 0.80

Long-term health and development of children diagnosed prenatally with a de novo apparently balanced chromosomal rearrangement. Prenat Diagn (2013) 0.80

The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research. Clin Sarcoma Res (2013) 0.79

Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer. Fam Cancer (2014) 0.79

Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians. Soc Sci Med (2004) 0.79